Exactech (EXAC) announced the successful first U.S. revision knee procedure using the ExactechGPS® Guided Personalized Surgery system.
The revision total knee application recently received FDA 510(k) clearance in the U.S. (under Blue Ortho) and approval in the European Union. EXAC acquired the system's co-developer, Blue Ortho, in 1Q15.
Within the last 12 months, EXAC has launched new revision implant systems, including the Optetrak Logic® CC Comprehensive Revision Knee.
Sources: Exactech, Inc.; ORTHOWORLD Inc.